Cargando…
P1488: COMBINING ALK2 INHIBITION WITH A MODIFIED ACTIVIN RECEPTOR IIA LIGAND TRAP PROVIDED ADDITIVE BENEFITS IN RESOLVING ANEMIA IN A MOUSE MODEL OF ANEMIA OF INFLAMMATION
Autores principales: | Wang, Chia-Yu, Melgar-Bermudez, Emiliano, Welch, Diana, Tseng, Claire, Fisher, Ffolliott, Cadena, Samuel, Lerner, Lorena, Seehra, Jasbir, Lachey, Jenn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429790/ http://dx.doi.org/10.1097/01.HS9.0000972836.25313.6f |
Ejemplares similares
-
P992: A MODIFIED ACTIVIN RECEPTOR TYPE II LIGAND TRAP RKER-050 RESTORED ERYTHROPOIESIS IN A MOUSE MODEL OF MYELOFIBROSIS
por: Moses, Blake, et al.
Publicado: (2023) -
P1567: ALK2 INHIBITION LOWERED HEPCIDIN AND LIBERATED SPLEEN IRON FOR ERYTHROPOIESIS IN ANEMIA OF INFLAMMATION
por: Wang, C.-Y., et al.
Publicado: (2022) -
Inhibition of the Activin Receptor Type-2B Pathway Restores Regenerative Capacity in Satellite Cell-Depleted Skeletal Muscle
por: Formicola, Luigi, et al.
Publicado: (2018) -
Arquitectura del renacimiento en España, 1488-1599 /
por: Nieto Alcaide, Víctor Manuel
Publicado: (1997) -
An activin receptor IIA ligand trap promotes erythropoiesis resulting in a rapid induction of red blood cells and haemoglobin
por: Carrancio, Soraya, et al.
Publicado: (2014)